首页> 美国卫生研究院文献>Internal Medicine >The Prognostic Impact of Dose-attenuated R-CHOP Therapy for Elderly Patients with Diffuse Large B-cell Lymphoma

【2h】

The Prognostic Impact of Dose-attenuated R-CHOP Therapy for Elderly Patients with Diffuse Large B-cell Lymphoma

机译：减毒R-CHOP疗法对老年弥漫性大B细胞淋巴瘤患者的预后影响

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective Although R-CHOP (rituximab, cyclophosphamide, vincristine, doxorubicin, and prednisone) is a standard therapy for diffuse large B-cell lymphoma (DLBCL), the optimal dose for elderly patients remains unclear.

机译：目的尽管R-CHOP（利妥昔单抗，环磷酰胺，长春新碱，阿霉素和泼尼松）是弥漫性大B细胞淋巴瘤（DLBCL）的标准疗法，但对于老年患者的最佳剂量仍不清楚。

著录项

期刊名称 Internal Medicine
作者
Akira Tanimura; Risen Hirai; Miki Nakamura; Masataka Takeshita; Shotaro Hagiwara; Akiyoshi Miwa;
展开▼
作者单位

展开▼
年(卷),期 2018(57),24
年度 2018
页码 3521–3528
总页数 8
原文格式 PDF
正文语种
中图分类基础医学;
关键词
DLBCL R-CHOP elderly comorbidities dose-attenuation;

机译：DLBCL;R-CHOP;老年人;合并症;减毒;

相似文献

外文文献
中文文献
专利

1. The Prognostic Impact of Dose-attenuated R-CHOP Therapy for Elderly Patients with Diffuse Large B-cell Lymphoma [J] . Akira Tanimura, Risen Hirai, Miki Nakamura, Internal medicine. . 2018,第24期

机译：减毒R-CHOP疗法对老年弥漫性大B细胞淋巴瘤患者的预后影响
2. The Prognostic Impact of Dose-attenuated R-CHOP Therapy for Elderly Patients with Diffuse Large B-cell Lymphoma [J] . Akira Tanimura, Risen Hirai, Miki Nakamura, Internal medicine. . 2018,第24期

机译：减毒R-CHOP疗法对老年弥漫性大B细胞淋巴瘤患者的预后影响
3. Prognostic impact of serum soluble interleukin-2 receptor level at diagnosis in elderly patients with diffuse large B-cell lymphoma treated with R-CHOP [J] . Kento Umino, Shin-Ichiro Fujiwara, Daisuke Minakata Leukemia and lymphoma . 2019,第3a4期

机译：血清可溶性白细胞介素-2受体水平对老年弥漫性大型B细胞淋巴瘤诊断患者血清血清可溶性白细胞介素-2受体水平的预后影响
4. Survival Prediction in Patients with Diffuse Large B-cell Lymphoma Using Logistic and Neural Network Models [C] . Chin-Chuan Chang, Chien-Hua Chen, Jer-Guang Hsieh, IEEE Eurasia Conference on Biomedical Engineering, Healthcare and Sustainability . 2021

机译：逻辑和神经网络模型弥漫性大B细胞淋巴瘤患者的存活预测
5. The Impact of Diffuse Large B-Cell Lymphoma on Primary Care and Costs of Chronic Conditions in Elderly Medicare Beneficiaries [D] . Garg, Rahul 2017

机译：弥漫性大B细胞淋巴瘤对老年医疗保险受益人的初级保健和慢性病费用的影响
6. The Prognostic Impact of Comorbidities in Patients with De-Novo Diffuse Large B-Cell Lymphoma Treated with R-CHOP Immunochemotherapy in Curative Intent [O] . Florian Kocher, Michael Mian, Andreas Seeber, 2020

机译：R-CHOP免疫化学疗法治疗合并De-Novo弥漫性大B细胞淋巴瘤对合并症的预后影响
7. The Prognostic Impact of Dose-attenuated R-CHOP Therapy for Elderly Patients with Diffuse Large B-cell Lymphoma [O] . Akira Tanimura, Risen Hirai, Miki Nakamura, 2018

机译：剂量减毒R-Chop治疗对老年弥漫性大B细胞淋巴瘤患者的预后影响

The Prognostic Impact of Dose-attenuated R-CHOP Therapy for Elderly Patients with Diffuse Large B-cell Lymphoma

摘要

著录项

相似文献

相关主题

期刊订阅